Xterna

Starna Therapeutics

This biotechnology company develops messenger RNA medicines and extrahepatic delivery systems for pharmaceutical firms and clinical researchers.

Etherna

This company develops mRNA and lipid nanoparticle technologies for pharmaceutical and biotechnology partners to create nucleic acid-based medicines and vaccines.

ExcepGen

ExcepGen develops a platform for nucleic acid therapeutics to improve the efficacy and tolerability of mRNA-based medicines for biopharmaceutical companies.

Kerna

This company develops an artificial intelligence platform to design and deliver messenger ribonucleic acid medicines for patients with previously untreatable conditions.

Marina

This company develops nucleic acid therapeutics and delivery technologies for patients with rare diseases, arthritis, hypertension, and cancer.

Averna Therapeutics

This biotechnology company develops genomic medicines using RNA-based technology to insert therapeutic genes into safe genomic locations for patients with various diseases.

DTX Pharma

This biotechnology firm develops RNA-based therapeutics for patients with rare neuromuscular and central nervous system disorders using a proprietary fatty acid delivery platform.

Spot Biosystems

This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.